Arrowhead Pharmaceuticals, Inc.
- ARWR
- NASDAQ
- Biotechnology
- RNAi Therapeutics
- Gene Silencing
$55.90
Today −4.44%Quote Oct 16, 2026, 08:00 PM UTC
−17.48%over the last month
Max drawdown −22.2%From 1-month high −22.2%3 months −22.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$7.90B
Quote Oct 16
Next earnings
Nov 24
Expected, not confirmed
Analyst target
$101.56
+81.7% from here
Floor
$54.17
3.1% below price
Where the price sits
22 analysts
Analyst range, low to high
$46.00$126.00
- Price $55.90
- Resistance $56.69
- Consensus $101.56
The price is right under resistance. Analysts' average target sits about 82% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ARWRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
711
Founded
1989